AI diagnosing in a matter of minutes.
TB-AI, a pioneering startup from Pakistan, proudly announced its successful participation at GITEX Africa 2024, where it unveiled its state-of-the-art AI diagnostic software. The event, held in the vibrant city of Marrakech, served as an excellent platform for TB-AI to present its innovative technology to a global audience, highlighting the software’s potential to transform the landscape of communicable disease diagnosis.
TB-AI’s participation in GITEX Africa 2024 marked a significant milestone for the startup. The company showcased its AI diagnostic software, designed to diagnose communicable diseases with remarkable speed and accuracy. The software delivers highly sensitive and specific results within minutes, significantly reducing human error and alleviating the human capacity burden in healthcare settings. Additionally, TB-AI’s solution is cost-effective, making it accessible to a wide range of healthcare providers.
By leveraging advanced GenAI algorithms, TB-AI’s software analyzes diagnostic data swiftly and accurately, ensuring timely intervention and treatment. This innovative approach enhances diagnostic precision, optimizes resource allocation, and ultimately improves patient outcomes.
Valuable Participation
Participating in GITEX Africa 2024 proved to be a worthwhile endeavor for TB-AI. The event offered an exceptional opportunity to engage with potential investors, partners, and industry leaders. The positive reception and significant interest in TB-AI’s technology underscored its potential impact on global healthcare.
“We are elated with the response TB-AI received at GITEX Africa 2024. The event provided a fantastic platform to showcase our cutting-edge AI diagnostic software to a diverse and influential audience,” said Dr. Hira Fareed, Founder & CEO at TB-AI. “The feedback and interest we garnered have been overwhelmingly positive, reaffirming our belief in the transformative power of our technology.”